Giulia Casorati
Overview
Explore the profile of Giulia Casorati including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
80
Citations
2143
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Belmonte B, Spada S, Allavena P, Benelli M, Bronte V, Casorati G, et al.
J Exp Clin Cancer Res
. 2025 Feb;
44(1):57.
PMID: 39966867
From 17 to 19th October 2024, the XXI Italian Network for Bio-Immunotherapy of Tumors Meeting (NIBIT) took place in Palermo, in the marvelous historical location of Teatro Politeama, under the...
2.
Tout I, Bougarn S, Toufiq M, Gopinath N, Hussein O, Sathappan A, et al.
J Transl Med
. 2025 Feb;
23(1):193.
PMID: 39962504
Background: Colorectal cancer (CRC) initiating cells (CICs) possess self-renewal capabilities and are pivotal in tumor recurrence and resistance to conventional therapies, including immunotherapy. The mechanisms underlying their interaction with immune...
3.
Zhou X, Wang Y, Dou Z, Delfanti G, Tsahouridis O, Pellegry C, et al.
Nat Cancer
. 2024 Oct;
5(11):1607-1621.
PMID: 39354225
Human natural killer T (NKT) cells have been proposed as a promising cell platform for chimeric antigen receptor (CAR) therapy in solid tumors. Here we generated murine CAR-NKT cells and...
4.
Ronzio M, Bernardini A, Taglietti V, Ceribelli M, Donati G, Gallo A, et al.
Genomics
. 2024 Jul;
116(5):110895.
PMID: 39025317
NF-Y is a Transcription Factor that regulates transcription through binding to the CCAAT-box. To understand its strategy, we analyzed 16 ChIP-seq datasets from human and mouse cells. Shared loci, mostly...
5.
Landoni E, Woodcock M, Barragan G, Casirati G, Cinella V, Stucchi S, et al.
Nat Commun
. 2024 Jun;
15(1):5182.
PMID: 38890345
No abstract available.
6.
Landoni E, Woodcock M, Barragan G, Casirati G, Cinella V, Stucchi S, et al.
Nat Commun
. 2024 Jan;
15(1):89.
PMID: 38167707
Human natural killer T cells (NKTs) are innate-like T lymphocytes increasingly used for cancer immunotherapy. Here we show that human NKTs expressing the pro-inflammatory cytokine interleukin-12 (IL-12) undergo extensive and...
7.
Delfanti G, Dellabona P, Casorati G
Bio Protoc
. 2023 Jul;
13(13):e4707.
PMID: 37449036
Invariant natural killer T (iNKT) cells are a non-conventional T-cell population expressing a conserved semi-invariant T-cell receptor (TCR) that reacts to lipid antigens, such as α-galactosyl ceramide (α-GalCer), presented by...
8.
Potenza A, Balestrieri C, Spiga M, Albarello L, Pedica F, Manfredi F, et al.
Gut
. 2023 Jul;
72(10):1887-1903.
PMID: 37399271
Objective: Colorectal tumours are often densely infiltrated by immune cells that have a role in surveillance and modulation of tumour progression but are burdened by immunosuppressive signals, which might vary...
9.
Arbore G, Albarello L, Bucci G, Punta M, Cossu A, Fanti L, et al.
Cancer Res
. 2023 Jun;
83(17):2873-2888.
PMID: 37350667
Significance: Multidimensional profiling of pretreatment esophageal adenocarcinoma shows patient response to nCT is correlated with active preexisting immunity and indicates molecular pathways of resistance that may be targeted to improve...
10.
Saavedra-Avila N, Dellabona P, Casorati G, Veerapen N, Besra G, Howell A, et al.
Front Immunol
. 2022 Oct;
13:1011209.
PMID: 36263021
Invariant natural killer T (iNKT) cells mediate immune responses when stimulated by glycolipid agonists presented by CD1d. In extensive studies of synthetic analogues of α-galactosyl ceramides, we identified numerous examples...